Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq: AGTC), announced today the successful completion of the previously announced tender offer (the “Offer”) to purchase all of the issued and outstanding shares of common stock of AGTC by a portfolio company of Syncona Limited (LON: SYNC) (“Syncona”). AGTC is a clinical-stage biotechnology company developing genetic therapies for people with rare and debilitating ophthalmic, otologic and central nervous system (CNS) diseases.
Read the full article: Syncona Limited Portfolio Company Successfully Completes Tender Offer and Acquisition of Applied Genetic Technologies Corporation //
Source: https://www.globenewswire.com/news-release/2022/12/01/2565756/30580/en/Syncona-Limited-Portfolio-Company-Successfully-Completes-Tender-Offer-and-Acquisition-of-Applied-Genetic-Technologies-Corporation.html